Immune responses in mice induced by HSV-1 glycoproteins presented with ISCOMs or NISV delivery systems

Vaccine

Volumn 14, Issue 17-18, 1996, Pages 1581-1589

  Hassan, Y ^a   Brewer, J M ^b   Alexander, J ^b   Jennings, R ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b UNIVERSITY OF STRATHCLYDE   (United Kingdom)

Author keywords

adjuvants; HSV 1; ISCOMs; NISV; Th1, Th2

Indexed keywords

ADJUVANT; HERPES VACCINE; ISCOM; NIOSOME; VIRUS ANTIGEN; VIRUS GLYCOPROTEIN;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; HERPES; HERPES SIMPLEX VIRUS 1; IMMUNE RESPONSE; IMMUNOGENICITY; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; CELL DIVISION; CELLS, CULTURED; CERCOPITHECUS AETHIOPS; CYTOKINES; DRUG CARRIERS; GLYCOPROTEINS; HERPESVIRUS 1, HUMAN; ISCOMS; LIPOSOMES; MICE; SPLEEN; SURFACE-ACTIVE AGENTS; VERO CELLS;

EID: 0030467147     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(96)00155-7     Document Type: Article

References (67)

1. 1 Nahmias, A., Vistine, A., Caldwell, A. and Wilson, C. Eye infections. Surv. Ophthamol. 1976, 21, 100-109
2. 2 Hazen, P.G. and Eppes, R.B. Eczema herpeticum caused by herpes virus type 2. Arch. Dermat. 1977, 113, 1085-1086
3. 3 Easty, D.L. Clinical aspects of ocular herpes simplex virus infection. In: Viral Diseases of the Eyes. Lloyd-Luke, London 1985, pp. 135-178
4. 4 Whitley, R.J. and Hutto, C. Neonatal herpes simplex virus infections. Paed. Rev. 1985, 7, 119-126
5. 5 Gutman, L.T., Wilfort, C.M. and Eppes, R.B. Herpes simplex virus encephalitis in children: analysis of cerebrospinal fluid and progressive neurodevelopment deterioration. Scand. J. Inf. Dis. 1986, 154, 415-421
6. 6 Quinnan, G.V., Masur, H., Rook, A.M. et al. Herpes virus infection in acquired immune deficiency. J. Am. Med. Assoc. 1984, 252, 72-77
7. 7 Whitley, R., Arvin, A., Prober, C. et al. Predictors of morbidity and mortality in neonates with herpes simplex virus infection. N. Eng. J. Med. 1991, 154, 415-421
8. 8 Watson, R.J. and Enquist, L.W. Genetically engineered herpes simplex virus vaccines. Prog. Med. Virol. 1985, 31, 84-108
9. 9 Stanberry, L.R., Bernstein, D.I., Burke, R.L., Pachl, C. and Meyers, M.G. Recombinant herpes simplex virus glycoprotein vaccines protect against initial and recurrent genital herpes. J. Inf. Dis. 1987, 157, 914-920
10. 10 Kino, Y. Yeast-derived glycoprotein B-1 of herpes simplex virus (HSV) as a candidate for an HSV vaccine. Adv. Exp. Med. Biol. 1990, 278, 183-190
11. 11 Erturk, M., Jennings, R., Phillpotts, R.J. and Potter, C.W. Biochemical characterisation of herpes simplex virus type-1-immunostimulating complexes (ISCOMs): a multi-glycoprotein structure. Vaccine 1991, 9, 668-674
12. 12 Wachsman, M., Luo, J.H., Aurelian, L. and Paoletti, E. Protection from herpes simplex virus type-2 is associated with T cells involved in delayed type hypersensitivity that recognise glycosylation-related epitopes on glycoprotein D. Vaccine 1992, 10, 447-454
13. 13 Nesburn, A.B., Burke, R.L., Ghiasi, H., Slanina, S., Bahri, S. and Wechsler, S.L. Vaccine therapy for ocular herpes simplex virus (HSV) infection: periocular vaccination reduces spontaneous ocular HSV type-1 shedding in latently infected rabbits. J. Virol. 1994, 68, 5084-5092
14. 14 Ghiasi, H., Kawar, R., Nesburn, A.B., Slanina, S. and Wechsler, S. Expression of seven herpes simplex virus type-1 glycoproteins (gB, gC, gD, gE, gG, gH and gI): comparative protection against lethal challenge in mice. J. Virol. 1994, 68, 2118-2126
15. 15 Stannard, L.M., Fuller, A.O. and Spear, P.G. Herpes simplex virus glycoproteins associated with different morphological entities projecting from the virion envelope. J. Gen. Virol. 1987, 68, 715-725
16. 16 Meignier, B., Jourdier, T.M., Norrild, B., Pereira, L. and Roizman, B. Immunisation of experimental animals with reconstituted glycoprotein mixtures of Herpes simplex virus 1 and 2: protection against challenge with virulent virus. J. Inf. Dis. 1987, 155, 921-930
17. 17 Erturk, M., Phillpotts, R.J., Welch, M.J. and Jennings, R. Efficacy of HSV-1 ISCOM vaccine in guinea-pig model of HSV-2 infection. Vaccine 1991, 9, 728-734
18. 18 Burke, R.L. Development of a herpes simplex virus subunit vaccine for prophylactic and therapeutic use. Rev. Inf. Dis. 1991, 13Suppl. 11, 5906-5911
19. 19 Erturk, M., Jennings, R., Hockley, D. and Potter, C.W. Antibody responses and protection in mice immunised with herpes simplex virus type-1 antigen immuno-stimulating complex preparations. J. Gen. Virol. 1989, 70, 2149-2155
20. 20 Byars, N.E., Fraser-Smith, E.B., Pecyk, R.A. et al. Vaccinating guinea-pigs with recombinant glycoprotein D of herpes simplex virus in an efficacious adjuvant formulation elicits protection against vaginal infection. Vaccine 1994, 12, 200-209
21. 21 Morein, B., Sundquist, B., Hoglund, S., Dalsgaard, K. and Osterhaus, A. ISCOM, a novel structure for antigenic presentation of membrane proteins from enveloped viruses. Nature 1984, 308, 457-460
22. 22 Ciaassen, I.J.T.M., Osterhaus, A.D.M.E. and Claassen, E. Antigen dectection in vivo after immunisation with different presentation forms of rabies virus antigen: involvement of marginal metallophilic macrophages in the uptake of immune-stimulating complexes. Eur. J. Immun. 1995, 25, 1446-1452
23. 23 De Vries, P., Uytdehaag, F.C.G.M. and Osterhaus, A.D.M.E. Canine distemper virus (CDV) immune-stimulating complexes (ISCOMs), but not measles virus ISCOMs, protect dogs against CDV infection. J. Gen. Virol. 1988, 69, 2071-2083
24. 24 Lovgren, K., Kaberg, H. and Morein, B. An experimental subunit vaccine (ISCOM) induced protective immunity to influenza virus infection in mice after a single intranasal administration. Clin. Exp. Immun. 1990, 82, 435-439
25. 25 Fekadu, M., Shaddock, J.H., Ekstrom, J. et al. An immune-stimulating complex subunit rabies vaccine protects mice and dogs against street rabies challenge. Vaccine 1992, 10, 192-197
26. 26 Trudel, M., Naden, RF., Séguin, C., Brault, S., Lusignan, Y. and Lemieux, S. Initiation of cytotoxic T-cell response and protection of Balb/c mice by vaccination with an experimental ISCOMs respiratory syncytial virus subunit vaccine. Vaccine 1992, 10, 107-127
27. 27 Fossum, C., Bergstrom, M., Lovgren, K., Watson, D.L. and Morein, B. Effect of ISCOMs and their adjuvant moeity (matrix) on the initial proliferation and IL-2 responses: comparison of spleen cells from mice inoculated with ISCOMs and/or matrix. Cell. Immun. 1990, 129, 414-425
28. 28 Takahashi, H., Takeshita, T., Morein, B., Putney, S., Germain, R.N. and Berzofsky, J. Induction of CD8+ cytotoxic T cells by immunisation with purified HIV-1 envelope proteins in ISCOMs. Nature 1990, 344, 873-875
29. 29 Villacress-Eriksson, M., Bergstrom-Mollaoglu, M., Kaberg, H. and Morein, B. Involvement of interleukin-2 and interferon-gamma in the immune response induced by influenza virus ISCOMs. Scand. J. Immun. 1992, 36, 421-426
30. 30 Kensil, C.R., Patel, U., Lennick, M. and Marciani, D. Separation and characterisation of saponins with adjuvant activity from Quillaja saponaria molina cortex. J. Immun. 1991, 146, 431-437
31. 31 Brewer, J.M. and Alexander, J. The adjuvant activity of nonionic surfactant vesicles (niosomes) on the Balb/c humoral response to bovine serum albumin. Immunology 1992, 75, 570-575
32. 32 Brewer, J.M., Roberts, C.W., Stimson, W.H. and Alexander, J. Accurate determination of adjuvant associated protein or peptide by ninhydrin assay. Vaccine 1995, 13, 1441-1444
33. 33 Grun, J.L. and Maurer, P.H. Different T helper cell subsets elicited in mice utilising two different adjuvant vehicles: the role of endogenous IL-1 in proliferate responses. Cell. Immun. 1989, 121, 134-145
34. 34 Snapper, C.M. and Paul, W.E. Interferon-Y and B cell stimulatory factor-1 reciprocally regulate immunoglobulin isotype control. Science 1987, 239, 944-947
35. 35 Snapper, C.M. and Mond, J.J. Towards a comprehensive view of immunoglobulin class switching. Immun. Today 1993, 14, 15-17
36. 36 Mosmann, T.R., Cherwinski, H., Bond, M.W., Qiedlin, M.A. and Coffman, R.L. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immun. 1986, 136, 2348-2357
37. 37 Mosmann, T.R. and Coffman, R.L. Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Ann. Rev. Immun. 1989, 7, 145-173
38. 38 Suzuki, Y., Conely, F.K. and Remington, J.S. Importance of endogenous IFN-γ for prevention of toxoplasmic encephalitis in mice. J. Immun. 1989, 143, 2045-2050
39. 39 Parker, S.J., Roberts, C.W. and Alexander, J. CD8+ T cells are the major lymphocyte population involved in protective immune response to Toxoplasma gondii in mice. Clin. Exp. Immun. 1991, 84, 207-212
40. 40 Gazzinelli, R.T., Hakim, F.T., Hieny, S., Shearer, G.M. and Sher, A. Synergistic role of CD4+ and CD8+ T lymphocytes in IFN-γ production and protective immunity induced by an attenuated T. gondii vaccine. J. Immun. 1991, 146, 286-292
41. 41 Roberts, C.W., Brewer, J.M. and Alexander, J. Congenital toxoplasmosis in the Balb/c mouse: prevention of vertical disease transmission and fetal death by vaccination. Vaccine 1994, 12, 1389-1394
42. 42 Jennings, R. and Erturk, M. Comparative studies of HSV-1 antigens solubilised from infected cells by using non-ionic or zwitterionic detergents. J. Med. Virol. 1990, 31, 98-108
43. 43 Erturk, M., Hill, T.J., Shimeld, C.A. and Jennings, R. Acute and latent infection of mice immunised with HSV-1 ISCOM vaccine. Arch. Virol. 1992, 125, 87-101
44. 44 Pick, U. Liposomes with a large trapping capacity prepared by freezing and thawing of sonicated phospholipid mixtures. Arch. Biochem. Biophys. 1981, 212, 195-203
45. 45 Bradford, M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilising the principle of protein dye binding. Analyt. Biochem. 1976, 72, 248-258
46. 46 Walker, W., Brewer, J.M. and Alexander, J. Entrapment of antigen in lipid vesicles modulates the immune response of human-PBL reconstituted SCID mice to influenza A antigens. Eur. J. Immun. 1996, 26, 1664-1667
47. 47 Allen, G. Laboratory Techniques in Biochemistry and Molecular Biology, Vol. 9. Sequencing of proteins and peptides (Eds Work, T.S. and Burdon R.H.). Elsevier Biomedical Press, North Holland, 1981, pp. 135-160
48. 48 Boggs, J.M., Hashim, G.A., Day, E.G. and Moscarello, M.A. Lipid induced recognition of a conformational determinant (residues 65 to 83) in myelin basic protein. J. Immun. 1985, 133, 2617-2622
49. 49 Lausch, R.N., Staats, H., Oakes, J.E., Cohen, G.H. and Eisenberg, R.J. Prevention of herpes keratitis by monoclonal antibodies specific for discontinous and continous epitopes on glycoprotein D. Invest Opthamol. Vis. Sci. 1991, 32, 2735-2740
50. 50 Spiegelberg, H.L Biological activities of immunoglobulins of different classes and subclasses. Adv. Immun. 1974, 19, 259-294
51. 51 Kipps, J., Parham, P., Punt, J. and Herzenberg, A. Importance of immunological isotype in human antibody-dependent cell-mediated cytotoxicity directed by murine monoclonal antibodies. J. Exp. Med. 1985, 161, 1-17
52. 52 Courtier, J.-P., Van de Logt, J.T.M., Heesen, F.W.A., Warnier, G. and Van Snick, J. IgG2a restriction of murine antibodies elicited by viral infections. J. Exp. Med. 1987, 165, 64-69
53. 53 Snapper, C.M., Waegell, W., Beernink, H. and Dasch, J.R. Transforming growth factor-β1 is required for secretion of IgG of all subclasses by LPS-activated murine B cells in vitro. J. Immun. 1993, 151, 4625-4636
54. 54 Nagelkerken, L., Gollob, K.J., Tielemans, M. and Coffman, R.L. Role of transforming growth factor-beta in the preferential induction of T helper cells of type-1 by staphylococcal enterotoxin B. Eur. J. Immun. 1993, 23, 2306-2310
55. 55 Cunningham, A.L. and Noble, J.R. Role of keratinocytes in human recurrent herpetic lesions. Ability to present herpes simplex virus antigens and act as a target for T lymphocyte cytotoxicity in vitro. J. Clin. Invest. 1989, 83, 490-496
56. 56 Schmid, D.S. and Mawle, A.C. T cell responses to herpes simplex viruses in humans. Rev. Inf. Dis. 1991, 13Suppl. 11, 5946-5949
57. 57 Simmons, A., Tscharke, D.C. and Speck, P. The role of immune mechanisms in control of herpes simplex virus infections of the peripheral nervous system. Curr. Topics Microbiol Immun. 1992, 179, 31-56
58. 58 Martin, S. and Rouse, B.T. The mechanisms of antiviral immunity induced by a vaccinia virus recombinant expressing herpes simplex virus type 1 gtycoprotein D: clearance of local infection. J. Immun. 1987, 138, 3431-3437
59. 59 Al-Ghamdi, A., Jennings, R., Bentley, H. and Potter, C.W. Latent HSV-1 Infection in mice immunised with a zwitterionic detergent-extracted HSV-1 antigen preparation. Arch. Virol. 1989, 106, 19-31
60. 60 Kohl, S. Role of antibody-dependent cellular cytotoxicity in defense against herpes simplex virus infections. Rev. Inf. Dis. 1991, 13, 108-114
61. 61 Ben-Ahmeida, E.T.S., Jennings, R., Erturk, M. and Potter, C.W. The IgG responses and protection in mice immunised with influenza antigens administered as ISCOMs with FCA ALH or as infectious virus. Arch. Virol. 1992, 125, 71-86
62. 62 Heeg, K., Kuon, W. and Wagner, H. Vaccination of class I major histocompatibility complex (MHC)-restricted murine CD8+ cytotoxic T lymphocytes towards soluble antigens: immune stimulating ovalbunim complexes enter the class I MHC-restricted antigen pathway and allow sensitization against the immunodominant peptide. Eur. J. Immun. 1991, 21, 1523-1527
63. 63 Valensi, J.M., Carison, J.R. and Van Nest, G.A. Systemic cytokine profiles in Balb/c mice immunised with trivalent influenza vaccine containing MF59 oil emulsion and other advanced adjuvants. J. Immun. 1994, 153, 4029-4039
64. 64 de Waal Malefyt, R., Haanen, J., Spits, H. et al. Interleukin 10 (IL10) and viral IL10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via down regulation of class II major histocompatibitity complex expression. J. Exp. Med. 1991, 174, 915-924
65. 65 Clerici, M. and Shearer, G.M. A Th1-Th2 switch as a critical step in the aetiology of HIV infection. Immun. Today 1993, 14, 107-110
66. 66 Osterhaus, A., Weijer, F., Uytdehaag, F.C.G.M., Jarrett, O., Sundquist, B. and Morein, B. Induction of immune response in cats by vaccination with feline leukemia virus ISCOM. J. Immun. 1965, 135, 591-596
67. 67 Mumford, J.A., Jessett, D.M., Rollinson, E.A., Hannant, D. and Draper, M.E. Duration of protective efficacy of equine influenza immunostimulating complex/tetanus vaccine. Vet. Record 1994, 134, 158-162